dexcom g4 sensor Search Results


90
Dexcom Inc g4 platinum cgm sensor
G4 Platinum Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 platinum cgm sensor/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 platinum cgm sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc cgm sensors, transmitters, and receivers g4 platinum with share
Cgm Sensors, Transmitters, And Receivers G4 Platinum With Share, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgm sensors, transmitters, and receivers g4 platinum with share/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
cgm sensors, transmitters, and receivers g4 platinum with share - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc continuous glucose monitor & subcutaneous glucose sensor dexcom g4
Continuous Glucose Monitor & Subcutaneous Glucose Sensor Dexcom G4, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitor & subcutaneous glucose sensor dexcom g4/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
continuous glucose monitor & subcutaneous glucose sensor dexcom g4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc diabetes assistant (dias) diabetes app dexcom g4 platinum sensor
Diabetes Assistant (Dias) Diabetes App Dexcom G4 Platinum Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/diabetes assistant (dias) diabetes app dexcom g4 platinum sensor/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
diabetes assistant (dias) diabetes app dexcom g4 platinum sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 version a sensor
G4 Version A Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 version a sensor/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 version a sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 platinum cgm system with 505 software
G4 Platinum Cgm System With 505 Software, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 platinum cgm system with 505 software/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 platinum cgm system with 505 software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 cgm sensor
G4 Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 cgm sensor/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 cgm sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc cgm noise model dexcom g4 glucose sensor
Cgm Noise Model Dexcom G4 Glucose Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgm noise model dexcom g4 glucose sensor/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
cgm noise model dexcom g4 glucose sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 cgm sensor and transmitter
G4 Cgm Sensor And Transmitter, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 cgm sensor and transmitter/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 cgm sensor and transmitter - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc sensor-augmented pump dexcom g4 platinum + animas vibe
Annual Transition Probabilities for the Type 1 Diabetes Markov Model
Sensor Augmented Pump Dexcom G4 Platinum + Animas Vibe, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sensor-augmented pump dexcom g4 platinum + animas vibe/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
sensor-augmented pump dexcom g4 platinum + animas vibe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 sensor adhesive
Annual Transition Probabilities for the Type 1 Diabetes Markov Model
G4 Sensor Adhesive, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 sensor adhesive/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 sensor adhesive - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4 ™ platinum/g5 ™ mobile sensors
Annual Transition Probabilities for the Type 1 Diabetes Markov Model
G4 ™ Platinum/G5 ™ Mobile Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4 ™ platinum/g5 ™ mobile sensors/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4 ™ platinum/g5 ™ mobile sensors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Annual Transition Probabilities for the Type 1 Diabetes Markov Model

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Transition Probabilities for the Type 1 Diabetes Markov Model

Article Snippet: 14 There was no direct evidence that continuous glucose monitoring prevented hospitalizations owing to hypoglycemic events, 25 , 33 , 39 so we did not consider this possibility in our model. table ft1 table-wrap mode="anchored" t5 Table 18: caption a7 Mean Cost ($) a Source First Year Subsequent Years Health State: Diabetes-Related Complications Nephropathy 80 13 O'Brien et al 2003 95 Neuropathy 192 192 O'Brien et al 2003 95 Retinopathy 492 52 O'Brien et al 2003 95 Severe hypoglycemic event (in-patient visit) 3,775 3,775 McQueen et al, 2015 97 Cardiovascular disease 18,682 4,072 O'Reilly et al, 2007 96 Blindness 3,483 2,482 O'Reilly et al, 2007 96 Lower-extremity amputation 43,984 6,024 O'Reilly et al, 2007 96 End-stage renal disease 28,221 12,808 O'Reilly et al, 2007 96 Intervention (Trade Name) Sensor-augmented pump (Dexcom G4 Platinum + Animas Vibe) 11,811 11,811 Dexcom and Animas b Sensor-augmented pump (Dexcom G5 Mobile + Animas Vibe) 11,534 11,534 Dexcom and Animas b Sensor-augmented pump with a low-glucose suspend feature (MiniMed Veo) 9,211 9,211 Medtronic b Standalone CGM plus multiple daily injections (Dexcom G4 Platinum) 10,097 10,097 Dexcom b Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) 8,587 8,587 Dexcom b SMBG plus insulin pump (Animas Vibe or MiniMed Veo) 6,817 6,817 Medtronic and Animas b SMBG plus multiple daily injections 3,677 3,677 Estimate c Open in a separate window Abbreviations: CGM, continuous glucose monitoring; SMBG, self-monitoring of blood glucose. a We used 25% of the mean cost for calculations of standard error in our probabilistic sensitivity analysis.

Techniques:

Annual Mortality for Diabetes Complications States

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Mortality for Diabetes Complications States

Article Snippet: 14 There was no direct evidence that continuous glucose monitoring prevented hospitalizations owing to hypoglycemic events, 25 , 33 , 39 so we did not consider this possibility in our model. table ft1 table-wrap mode="anchored" t5 Table 18: caption a7 Mean Cost ($) a Source First Year Subsequent Years Health State: Diabetes-Related Complications Nephropathy 80 13 O'Brien et al 2003 95 Neuropathy 192 192 O'Brien et al 2003 95 Retinopathy 492 52 O'Brien et al 2003 95 Severe hypoglycemic event (in-patient visit) 3,775 3,775 McQueen et al, 2015 97 Cardiovascular disease 18,682 4,072 O'Reilly et al, 2007 96 Blindness 3,483 2,482 O'Reilly et al, 2007 96 Lower-extremity amputation 43,984 6,024 O'Reilly et al, 2007 96 End-stage renal disease 28,221 12,808 O'Reilly et al, 2007 96 Intervention (Trade Name) Sensor-augmented pump (Dexcom G4 Platinum + Animas Vibe) 11,811 11,811 Dexcom and Animas b Sensor-augmented pump (Dexcom G5 Mobile + Animas Vibe) 11,534 11,534 Dexcom and Animas b Sensor-augmented pump with a low-glucose suspend feature (MiniMed Veo) 9,211 9,211 Medtronic b Standalone CGM plus multiple daily injections (Dexcom G4 Platinum) 10,097 10,097 Dexcom b Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) 8,587 8,587 Dexcom b SMBG plus insulin pump (Animas Vibe or MiniMed Veo) 6,817 6,817 Medtronic and Animas b SMBG plus multiple daily injections 3,677 3,677 Estimate c Open in a separate window Abbreviations: CGM, continuous glucose monitoring; SMBG, self-monitoring of blood glucose. a We used 25% of the mean cost for calculations of standard error in our probabilistic sensitivity analysis.

Techniques:

Utilities for Complications Health States

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Utilities for Complications Health States

Article Snippet: 14 There was no direct evidence that continuous glucose monitoring prevented hospitalizations owing to hypoglycemic events, 25 , 33 , 39 so we did not consider this possibility in our model. table ft1 table-wrap mode="anchored" t5 Table 18: caption a7 Mean Cost ($) a Source First Year Subsequent Years Health State: Diabetes-Related Complications Nephropathy 80 13 O'Brien et al 2003 95 Neuropathy 192 192 O'Brien et al 2003 95 Retinopathy 492 52 O'Brien et al 2003 95 Severe hypoglycemic event (in-patient visit) 3,775 3,775 McQueen et al, 2015 97 Cardiovascular disease 18,682 4,072 O'Reilly et al, 2007 96 Blindness 3,483 2,482 O'Reilly et al, 2007 96 Lower-extremity amputation 43,984 6,024 O'Reilly et al, 2007 96 End-stage renal disease 28,221 12,808 O'Reilly et al, 2007 96 Intervention (Trade Name) Sensor-augmented pump (Dexcom G4 Platinum + Animas Vibe) 11,811 11,811 Dexcom and Animas b Sensor-augmented pump (Dexcom G5 Mobile + Animas Vibe) 11,534 11,534 Dexcom and Animas b Sensor-augmented pump with a low-glucose suspend feature (MiniMed Veo) 9,211 9,211 Medtronic b Standalone CGM plus multiple daily injections (Dexcom G4 Platinum) 10,097 10,097 Dexcom b Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) 8,587 8,587 Dexcom b SMBG plus insulin pump (Animas Vibe or MiniMed Veo) 6,817 6,817 Medtronic and Animas b SMBG plus multiple daily injections 3,677 3,677 Estimate c Open in a separate window Abbreviations: CGM, continuous glucose monitoring; SMBG, self-monitoring of blood glucose. a We used 25% of the mean cost for calculations of standard error in our probabilistic sensitivity analysis.

Techniques:

Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Article Snippet: 14 There was no direct evidence that continuous glucose monitoring prevented hospitalizations owing to hypoglycemic events, 25 , 33 , 39 so we did not consider this possibility in our model. table ft1 table-wrap mode="anchored" t5 Table 18: caption a7 Mean Cost ($) a Source First Year Subsequent Years Health State: Diabetes-Related Complications Nephropathy 80 13 O'Brien et al 2003 95 Neuropathy 192 192 O'Brien et al 2003 95 Retinopathy 492 52 O'Brien et al 2003 95 Severe hypoglycemic event (in-patient visit) 3,775 3,775 McQueen et al, 2015 97 Cardiovascular disease 18,682 4,072 O'Reilly et al, 2007 96 Blindness 3,483 2,482 O'Reilly et al, 2007 96 Lower-extremity amputation 43,984 6,024 O'Reilly et al, 2007 96 End-stage renal disease 28,221 12,808 O'Reilly et al, 2007 96 Intervention (Trade Name) Sensor-augmented pump (Dexcom G4 Platinum + Animas Vibe) 11,811 11,811 Dexcom and Animas b Sensor-augmented pump (Dexcom G5 Mobile + Animas Vibe) 11,534 11,534 Dexcom and Animas b Sensor-augmented pump with a low-glucose suspend feature (MiniMed Veo) 9,211 9,211 Medtronic b Standalone CGM plus multiple daily injections (Dexcom G4 Platinum) 10,097 10,097 Dexcom b Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) 8,587 8,587 Dexcom b SMBG plus insulin pump (Animas Vibe or MiniMed Veo) 6,817 6,817 Medtronic and Animas b SMBG plus multiple daily injections 3,677 3,677 Estimate c Open in a separate window Abbreviations: CGM, continuous glucose monitoring; SMBG, self-monitoring of blood glucose. a We used 25% of the mean cost for calculations of standard error in our probabilistic sensitivity analysis.

Techniques:

Sensitivity Analyses for Continuous Glucose Monitoring Model

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Sensitivity Analyses for Continuous Glucose Monitoring Model

Article Snippet: 14 There was no direct evidence that continuous glucose monitoring prevented hospitalizations owing to hypoglycemic events, 25 , 33 , 39 so we did not consider this possibility in our model. table ft1 table-wrap mode="anchored" t5 Table 18: caption a7 Mean Cost ($) a Source First Year Subsequent Years Health State: Diabetes-Related Complications Nephropathy 80 13 O'Brien et al 2003 95 Neuropathy 192 192 O'Brien et al 2003 95 Retinopathy 492 52 O'Brien et al 2003 95 Severe hypoglycemic event (in-patient visit) 3,775 3,775 McQueen et al, 2015 97 Cardiovascular disease 18,682 4,072 O'Reilly et al, 2007 96 Blindness 3,483 2,482 O'Reilly et al, 2007 96 Lower-extremity amputation 43,984 6,024 O'Reilly et al, 2007 96 End-stage renal disease 28,221 12,808 O'Reilly et al, 2007 96 Intervention (Trade Name) Sensor-augmented pump (Dexcom G4 Platinum + Animas Vibe) 11,811 11,811 Dexcom and Animas b Sensor-augmented pump (Dexcom G5 Mobile + Animas Vibe) 11,534 11,534 Dexcom and Animas b Sensor-augmented pump with a low-glucose suspend feature (MiniMed Veo) 9,211 9,211 Medtronic b Standalone CGM plus multiple daily injections (Dexcom G4 Platinum) 10,097 10,097 Dexcom b Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) 8,587 8,587 Dexcom b SMBG plus insulin pump (Animas Vibe or MiniMed Veo) 6,817 6,817 Medtronic and Animas b SMBG plus multiple daily injections 3,677 3,677 Estimate c Open in a separate window Abbreviations: CGM, continuous glucose monitoring; SMBG, self-monitoring of blood glucose. a We used 25% of the mean cost for calculations of standard error in our probabilistic sensitivity analysis.

Techniques: